When a stock hits a fresh high, it can mean that it’s on its way to greatness -- or that it has run its course. Even with the risk of the latter, searching for these outperformers can reveal companies that are doing something right, much to their investors' delight.

Let’s dig deeper
With that in mind, we'll use the aggregate intelligence of the 135,000-plus investors participating in Motley Fool CAPS to find stocks hitting 52-week highs today. The community's approval (signified by four- and five-star ratings) could be a sign that further research is in order.

Here are three such stocks:


Today’s Intraday Price


CAPS Rating (out of 5)

Fools Saying Outperform

Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)



4 Stars

1367 of 1419

Air Transport Services (NASDAQ:ATSG)


Air Freight and Logistics

4 Stars

285 of 308



Computers and Peripherals

2 Stars

354 of 406

Source: Motley Fool CAPS, as of July 1, 2009

Top-rated pharmaceuticals companies:

  • Noven Pharmaceuticals, Inc. (NASDAQ:NOVN): Stock price is 37% higher than last year.
  • Watson Pharmaceuticals, Inc. (NYSE:WPI): Stock price is 25% higher than last year.

Top-rated air freight and logistics companies:

  • Expeditors International of Washington (NASDAQ:EXPD): Stock price is 19% lower than last year.

Join us on CAPS to learn more about these and countless other interesting stock ideas.

Disclosure is important to us here at The Motley Fool. The stocks mentioned in this article received their CAPS ratings from participants in The Motley Fool's CAPS service and have hit 52-week highs during today's trading.

No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today’s market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool Pro, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.